Net profit of Sequent Scientific rose 464.75% to Rs 14.74 crore in the quarter ended September 2025 as against Rs 2.61 crore during the previous quarter ended September 2024. Sales rose 15.01% to Rs 423.99 crore in the quarter ended September 2025 as against Rs 368.65 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales423.99368.65 15 OPM %13.1310.61 - PBDT44.3229.32 51 PBT28.8612.22 136 NP14.742.61 465 Powered by Capital Market - Live News

Sequent Scientific has allotted 11,86,700 equity shares under ESOP on 11 November 2025. Consequent to the allotment of the aforesaid equity shares, the issued and the paid-up equity share capital of the Company will increase from Rs. 50,35,25,296 consisting of 25,17,62,648 equity shares of Rs. 2 each to Rs. 50,58,98,696 consisting of 25,29,49,348 equity shares of Rs. 2 each.Powered by Capital Market - Live News

Sequent Scientific will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News

Net profit of Sequent Scientific rose 119.82% to Rs 14.31 crore in the quarter ended June 2025 as against Rs 6.51 crore during the previous quarter ended June 2024. Sales rose 13.12% to Rs 441.42 crore in the quarter ended June 2025 as against Rs 390.21 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales441.42390.21 13 OPM %11.8210.75 - PBDT41.9028.25 48 PBT26.7712.00 123 NP14.316.51 120 Powered by Capital Market - Live News

Sequent Scientific will hold a meeting of the Board of Directors of the Company on 8 August 2025.Powered by Capital Market - Live News